A. . Wollenberg, “Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis”, Acta Derm Venereol, vol. 102, p. adv00726, May 2022.